✦ LIBER ✦

A phase I study of the biomodulation of capecitabine by docetaxel and gemcitabine (mGTX) in previously untreated patients with metastatic adenocarcinoma of the pancreas

✍ Scribed by Marisa E. Hill; Xiaobai Li; Sharon Kim; Angela Campbell; Kristy Culler; Mark Bloomston; Mark Zalupski; Gwen Hejna; Tanios Bekaii-Saab

Publisher: Springer
Year: 2010
Tongue: English
Weight: 266 KB
Volume: 67
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1348-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of gemcitabine and docet

A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors

✍ David P. Ryan; Thomas J. Lynch; Michael L. Grossbard; Michael V. Seiden; Charles 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

A Phase I study was initiated to determine the maximum tolerated dose of weekly gemcitabine combined with monthly, fixed-dose docetaxel. ## METHODS. Patients with metastatic solid tumors were treated with docetaxel, 60 mg/m 2 , on Day 1 every 28 days. Gemcitabine was administered on Days 1, 8, and

Phase I study of 3-weekly docetaxel, cap

Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer

✍ Sun Jin Sym; Min-Hee Ryu; Hye Jin Kang; Sung Sook Lee; Heung-Moon Chang; Jae Lyu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 328 KB

Phase II study of docetaxel and cisplati

Phase II study of docetaxel and cisplatin in patients with previously untreated metastatic non-small-cell lung cancer

✍ H. Okamoto; K. Watanabe; Y. Segawa; Y. Ichinose; A. Yokoyama; S. Yoneda; H. Niit 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 86 KB

Phase I study of docetaxel and cisplatin

Phase I study of docetaxel and cisplatin for patients with previously untreated metastatic non-small-cell lung cancer: a Japanese cooperative study

✍ Y. Segawa; K. Watanabe; S. Hiraki; K. Tominaga; I. Hayashi; M. Harada; M. Yamaki 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 92 KB

Second-line chemotherapy with Capecitabi

Second-line chemotherapy with Capecitabine (Xeloda) and Docetaxel (Taxotere) in previously treated, unresectable adenocarcinoma of pancreas: the final results of a phase II trial

✍ Ourania Katopodis; Aris Polyzos; Nikolaos Kentepozidis; Stylianos Giassas; Maria 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 335 KB

Intraperitoneal gemcitabine pharmacokine

Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas

✍ T. Clark Gamblin; Merrill J. Egorin; Eleanor G. Zuhowski; Theodore F. Lagattuta; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 314 KB